Healthcare

The latest edition of Medical Device TOE profiles a wide spectrum of innovations in the MedTech space. These innovation profiles present the latest product launches, recent scientific publications, and first-of-its-kind procedures that are certain to have an impact on the industry. This edition contains profiles of a novel drug-eluting stent, an ad...

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends. Precision clinical trial studies, glucose monitoring through smartphones, and gene editing to modify epigenetics are illustrated in the TOE. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and...

The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutio...

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across new technologies enabling drug discovery and development. The service encompasses recent advances in nutrient sensing, microfluidic assays, controlled drug delivery, nanosensing, DNA library screening, biosimilars, and breakthrough treatment platforms. Additionally, th...

This edition of the Genetic Technology TOE depicts the life sciences trends across recent genetic technology and biopharma advances. Genetic technology, biopharmaceuticals development and regulatory approval, CRISPR/Cas9 gene editing technology, and CAR-T cell therapy are profiled in the TOE. The corresponding clinical trials scenario for genetical...

Frost & Sullivan defines digital health to include telehealth and healthcare IT. Telehealth covers video telemedicine, remote patient monitoring (RPM), and mobile health (mHealth) and healthcare IT (in the APAC context) refers to the software solutions deployed across hospitals in the region. It is difficult to generalize or summarize the digital h...

30 Nov 2017  |  Europe  |  Market Research

Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021

Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth

Infographics

×

Key Issues Addressed

Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...

29 Nov 2017  |  Global  |  Market Research

Future of Smart Hospitals

Concept Definition, Application, and Growth Opportunities

Infographics

×

Key Issues Addressed

The entire industry has probably heard the term of ‘Smart Hospitals’ or the ‘Intelligent Hospitals’. However, only a few truly understand the concept, as there is plenty of ambiguity around the term, with each stakeholder defining it in a way that relates to themselves and their services. Some even confuse a digital hospital to a smart hosp...

This market insight aims to profile select medical device companies in Asia-Pacific for 2016. Research Scope: • The aim of this insight is to analyze and profile APAC medical device manufacturers, based on certain parameters. • It covers wound management, cardiovascular, orthopedic implants, infection control, and infusion...